These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 1750799)

  • 1. The endothelium: its role in scleroderma.
    Pearson JD
    Ann Rheum Dis; 1991 Nov; 50 Suppl 4(Suppl 4):866-71. PubMed ID: 1750799
    [No Abstract]   [Full Text] [Related]  

  • 2. The vascular endothelium in scleroderma.
    Kahaleh MB
    Int Rev Immunol; 1995; 12(2-4):227-45. PubMed ID: 7650422
    [No Abstract]   [Full Text] [Related]  

  • 3. A radical proposal for the pathogenesis of scleroderma.
    Murrell DF
    J Am Acad Dermatol; 1993 Jan; 28(1):78-85. PubMed ID: 8425975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The microvascular endothelium in scleroderma.
    Kahaleh B
    Rheumatology (Oxford); 2008 Oct; 47 Suppl 5():v14-5. PubMed ID: 18784128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The endothelium in the pathogenesis of systemic sclerosis: is it primary or secondary?
    Furst DE
    J Mal Vasc; 1999 May; 24(2):95-8. PubMed ID: 10399641
    [No Abstract]   [Full Text] [Related]  

  • 6. Large vessel arterial thrombosis in systemic sclerosis with antiphospholipid antibodies.
    Barile LA; Bravo G; Pizarro S
    J Rheumatol; 1990 Dec; 17(12):1721-2. PubMed ID: 2084259
    [No Abstract]   [Full Text] [Related]  

  • 7. Systemic sclerosis (scleroderma). Introduction.
    Black CM
    Ann Rheum Dis; 1991 Nov; 50 Suppl 4(Suppl 4):837-8. PubMed ID: 1750794
    [No Abstract]   [Full Text] [Related]  

  • 8. Lymphocyte interactions with the vascular endothelium in systemic sclerosis.
    Kahaleh B
    Clin Dermatol; 1994; 12(3):361-7. PubMed ID: 7954194
    [No Abstract]   [Full Text] [Related]  

  • 9. Pathogenesis of scleroderma. Current concepts.
    Lee EB; Anhalt GJ; Voorhees JJ; Diaz LA
    Int J Dermatol; 1984 Mar; 23(2):85-9. PubMed ID: 6698691
    [No Abstract]   [Full Text] [Related]  

  • 10. Chimerism in scleroderma.
    Aractingi S; Dausset J; Carosella ED
    Lancet; 1998 Jun; 351(9119):1886; author reply 1887. PubMed ID: 9652693
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunologic aspects of scleroderma.
    Korn JH
    Curr Opin Rheumatol; 1989 Dec; 1(4):479-84. PubMed ID: 2702049
    [No Abstract]   [Full Text] [Related]  

  • 12. [Disorders of cellular immunity in systemic scleroderma].
    Sierakowski SJ; Kucharz EJ
    Przegl Lek; 1988; 45(7):592-7. PubMed ID: 3070641
    [No Abstract]   [Full Text] [Related]  

  • 13. [Anti-cardiolipin antibodies and other immunological disorders in patients with systemic scleroderma].
    Speranskiĭ AI; Riazantseva TA; Guseva NG; Melkumova KL; Ivanova SM
    Revmatologiia (Mosk); 1990; (3):11-4. PubMed ID: 2098888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenesis of scleroderma: the interrelationship of the immune and vascular hypotheses.
    Sternberg EM
    Surv Immunol Res; 1985; 4(1):69-80. PubMed ID: 3890057
    [No Abstract]   [Full Text] [Related]  

  • 15. Reduced angiotensin converting enzyme plasma activity in scleroderma. A marker of endothelial injury?
    Matucci-Cerinic M; Pignone A; Lotti T; Spillantini G; Curradi C; Leoncini G; Iannone F; Falcini F; Cagnoni M
    J Rheumatol; 1990 Mar; 17(3):328-30. PubMed ID: 2159071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proceedings of the third international workshop on scleroderma research.
    Black CM; Korn JH
    Matrix Biol; 1995 Dec; 14(9):699-704. PubMed ID: 8785584
    [No Abstract]   [Full Text] [Related]  

  • 17. Quantifying role of nitric oxide in endothelial barrier regulation.
    Alexander JS; Okayama N
    Methods Enzymol; 1999; 301():3-13. PubMed ID: 9919548
    [No Abstract]   [Full Text] [Related]  

  • 18. Endothelial progenitor cells: novel players in the pathogenesis of rheumatic diseases.
    Distler JH; Beyer C; Schett G; Lüscher TF; Gay S; Distler O
    Arthritis Rheum; 2009 Nov; 60(11):3168-79. PubMed ID: 19877034
    [No Abstract]   [Full Text] [Related]  

  • 19. Is antiendothelial cell antibody the murder weapon in systemic sclerosis?
    Youinou P; Revelen R; Bordron A
    Clin Exp Rheumatol; 1999; 17(1):35-6. PubMed ID: 10084025
    [No Abstract]   [Full Text] [Related]  

  • 20. [Experimental models of systemic scleroderma].
    Serakovski S; Kukhazh E; Bernatska K
    Revmatologiia (Mosk); 1989; (3):36-46. PubMed ID: 2692123
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.